Hydatidiform Mole: Clinical Trials

2 trials for Hydatidiform Mole, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed. 2 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 22Completed 2

Follow Hydatidiform Mole: new trials by email Literature Review of Hydatidiform Mole trials Research Report on Hydatidiform Mole

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Second Curettage in Treating Patients With Persistent Non-metastatic Gestational Trophoblastic Tumors
Laboratory Biomarker Analysis, Therapeutic Conventional Surgery - Complete Hydatidiform Mole, Non-Metastatic Gestational Trophoblastic Tumor
Phase 2CompletedGynecologic Oncology Group642007-10-092017-08-24
A Trial for Patients With Gestational Trophoblastic Disease
Pemetrexed - Trophoblastic Neoplasms, Uterine Neoplasms
Phase 2CompletedEli Lilly and Company502006-07-012007-08-09

Narrower conditions

Choriocarcinoma (1)  ·  Trophoblastic Neoplasms (1)  ·  Uterine Neoplasms (1)

Broader conditions

Female Urogenital Diseases and Pregnancy Complications (2)  ·  Gestational Trophoblastic Disease (2)  ·  Neoplasms (2)  ·  Neoplasms by Histologic Type (2)  ·  Neoplasms, Germ Cell and Embryonal (2)  ·  Pregnancy Complications (2)  ·  Pregnancy Complications, Neoplastic (2)  ·  Urogenital Diseases (2)  ·  Adenocarcinoma (1)  ·  Carcinoma (1)  ·  Female Urogenital Diseases (1)  ·  Genital Diseases (1)  ·  Genital Diseases, Female (1)  ·  Genital Neoplasms, Female (1)  ·  Neoplasms by Site (1)

Interventions

Pemetrexed (1)

Sponsors

Eli Lilly and Company (1)  ·  Gynecologic Oncology Group (1)

Countries

United States (2)  ·  Canada (1)

Top investigators

David Miller, MD (1)  ·  Raymond Osborne (1)

Results publications

PMID 27500329

NIH funding

U10CA027469 (1), U10CA180868 (1)